These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 36768472)

  • 1. Clinical Trials in Prader-Willi Syndrome: A Review.
    Mahmoud R; Kimonis V; Butler MG
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
    Strong TV; Miller JL; McCandless SE; Gevers E; Yanovski JA; Matesevac L; Bohonowych J; Ballal S; Yen K; Hirano P; Cowen NM; Bhatnagar A
    J Neurodev Disord; 2024 Apr; 16(1):22. PubMed ID: 38671361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.
    Butler MG; Manzardo AM; Forster JL
    Curr Pediatr Rev; 2016; 12(2):136-66. PubMed ID: 26592417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
    Wevrick R
    Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
    Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
    Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
    Miller JL; Gevers E; Bridges N; Yanovski JA; Salehi P; Obrynba KS; Felner EI; Bird LM; Shoemaker AH; Angulo M; Butler MG; Stevenson D; Abuzzahab J; Barrett T; Lah M; Littlejohn E; Mathew V; Cowen NM; Bhatnagar A;
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1676-1685. PubMed ID: 36639249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prader-Willi Syndrome: Obesity due to Genomic Imprinting.
    Butler MG
    Curr Genomics; 2011 May; 12(3):204-15. PubMed ID: 22043168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome.
    Kimonis V; Surampalli A; Wencel M; Gold JA; Cowen NM
    PLoS One; 2019; 14(9):e0221615. PubMed ID: 31545799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.
    Butler MG; Miller JL; Forster JL
    Curr Pediatr Rev; 2019; 15(4):207-244. PubMed ID: 31333129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study.
    Wieting J; Jahn K; Eberlein CK; Bleich S; Frieling H; Deest M
    Behav Brain Res; 2023 Jul; 450():114494. PubMed ID: 37182741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic illness in people with Prader-Willi syndrome: a systematic review of clinical presentation, course and phenomenology.
    Aman LCS; Lester SD; Holland AJ; Fletcher PC
    Orphanet J Rare Dis; 2024 Feb; 19(1):69. PubMed ID: 38360662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.
    Madeo SF; Zagaroli L; Vandelli S; Calcaterra V; Crinò A; De Sanctis L; Faienza MF; Fintini D; Guazzarotti L; Licenziati MR; Mozzillo E; Pajno R; Scarano E; Street ME; Wasniewska M; Bocchini S; Bucolo C; Buganza R; Chiarito M; Corica D; Di Candia F; Francavilla R; Fratangeli N; Improda N; Morabito LA; Mozzato C; Rossi V; Schiavariello C; Farello G; Iughetti L; Salpietro V; Salvatoni A; Giordano M; Grugni G; Delvecchio M
    Front Endocrinol (Lausanne); 2024; 15():1382583. PubMed ID: 38737552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
    Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome.
    Wieting J; Jahn K; Buchholz V; Lichtinghagen R; Deest-Gaubatz S; Bleich S; Eberlein CK; Deest M; Frieling H
    Psychoneuroendocrinology; 2022 Sep; 143():105857. PubMed ID: 35803048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
    J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome.
    Avrahamy H; Pollak Y; Shriki-Tal L; Genstil L; Hirsch HJ; Gross-Tsur V; Benarroch F
    Compr Psychiatry; 2015 Apr; 58():189-97. PubMed ID: 25677112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.